Department of Rheumatology, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.
J Immunol Res. 2020 Oct 9;2020:8146502. doi: 10.1155/2020/8146502. eCollection 2020.
Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease that commonly causes kidney damage. Therefore, we measured plasma levels of cytokines that may be related to renal dysfunction in SLE patients.
To explore the differences between SLE patients with renal dysfunction and healthy volunteers, the levels of cytokines in plasma were screened using a human cytokine antibody array. Then, we chose fourteen of the elevated cytokines for verification with an expanded sample size by a human magnetic Luminex assay. Plasma samples were isolated from SLE patients ( = 72) and healthy volunteers ( = 8).
Cytokine antibody array data showed elevated plasma cytokines in SLE patients with renal dysfunction compared with healthy volunteers. By using the human magnetic Luminex assay, we found that plasma levels of CHI3L1, GDF-15, IGFBP-2, MIF, ST2, TFF3, and uPAR were significantly higher in SLE patients than in healthy volunteers. Plasma levels of CXCL4 were significantly lower in the active group than in the inactive group, and plasma levels of CHI3L1, IGFBP-2, MIF, and MPO were significantly higher in the active group than in the inactive group. We also analyzed the correlation between plasma cytokine levels and the SLEDAI-2K, and our results showed that the plasma levels of the fourteen selected cytokines were weakly correlated or not correlated with the SLEDAI-2K. We further analyzed the correlation between cytokines and renal dysfunction. Plasma levels of GDF-15 and TFF3 were highly positively correlated with serum creatinine levels and 24-hour urine protein levels.
Our data suggest that plasma levels of GDF-15 and TFF3 are potential renal dysfunction markers in SLE patients, but plasma levels of these cytokines are not correlated with the SLEDAI-2K. Further study is warranted to determine how these cytokines regulate inflammatory responses and renal dysfunction in SLE.
系统性红斑狼疮(SLE)是一种常见的慢性、系统性自身免疫性疾病,常导致肾脏损害。因此,我们测量了可能与 SLE 患者肾功能障碍相关的血浆细胞因子水平。
为了探讨肾功能障碍的 SLE 患者与健康志愿者之间的差异,我们使用人类细胞因子抗体阵列筛选了血浆中的细胞因子水平。然后,我们选择了 14 种升高的细胞因子,通过扩大样本量,用人磁珠 Luminex 检测进行验证。从 SLE 患者(n=72)和健康志愿者(n=8)中分离血浆样本。
细胞因子抗体阵列数据显示,肾功能障碍的 SLE 患者血浆中细胞因子水平升高。通过人磁珠 Luminex 检测,我们发现,与健康志愿者相比,SLE 患者的血浆 CHI3L1、GDF-15、IGFBP-2、MIF、ST2、TFF3 和 uPAR 水平显著升高。活动组的血浆 CXCL4 水平明显低于非活动组,活动组的 CHI3L1、IGFBP-2、MIF 和 MPO 水平明显高于非活动组。我们还分析了细胞因子与 SLEDAI-2K 的相关性,结果表明,这 14 种选定细胞因子的血浆水平与 SLEDAI-2K 呈弱相关或不相关。我们进一步分析了细胞因子与肾功能障碍的相关性。血浆 GDF-15 和 TFF3 水平与血清肌酐水平和 24 小时尿蛋白水平呈高度正相关。
我们的数据表明,血浆 GDF-15 和 TFF3 水平可能是 SLE 患者肾功能障碍的标志物,但这些细胞因子的血浆水平与 SLEDAI-2K 不相关。需要进一步研究来确定这些细胞因子如何调节 SLE 中的炎症反应和肾功能障碍。